Seeking Alpha

Shire (SHPG -0.2%) lags the overall market after JP Morgan/Cazenove cut the shares to Neutral,...

Shire (SHPG -0.2%) lags the overall market after JP Morgan/Cazenove cut the shares to Neutral, citing a lack of catalysts. The firm says its pipeline is now a 2014 story, as its Phase III studies of Vyvanse for depression, as well as versus Concerta for ADHD, aren't likely to have any impact over the near term.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector